Klopf, J.; Willixhofer, R.; Ahmadi-Fazel, D.; Scheuba, A.; Fuchs, L.; Sotir, A.; Wanhainen, A.; Brostjan, C.; Neumayer, C.; Eilenberg, W.
MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake—A Double-Blind, Randomized, and Placebo-Controlled Trial. Med. Sci. 2025, 13, 273.
https://doi.org/10.3390/medsci13040273
AMA Style
Klopf J, Willixhofer R, Ahmadi-Fazel D, Scheuba A, Fuchs L, Sotir A, Wanhainen A, Brostjan C, Neumayer C, Eilenberg W.
MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake—A Double-Blind, Randomized, and Placebo-Controlled Trial. Medical Sciences. 2025; 13(4):273.
https://doi.org/10.3390/medsci13040273
Chicago/Turabian Style
Klopf, Johannes, Robin Willixhofer, Diana Ahmadi-Fazel, Andreas Scheuba, Lukas Fuchs, Anna Sotir, Anders Wanhainen, Christine Brostjan, Christoph Neumayer, and Wolf Eilenberg.
2025. "MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake—A Double-Blind, Randomized, and Placebo-Controlled Trial" Medical Sciences 13, no. 4: 273.
https://doi.org/10.3390/medsci13040273
APA Style
Klopf, J., Willixhofer, R., Ahmadi-Fazel, D., Scheuba, A., Fuchs, L., Sotir, A., Wanhainen, A., Brostjan, C., Neumayer, C., & Eilenberg, W.
(2025). MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake—A Double-Blind, Randomized, and Placebo-Controlled Trial. Medical Sciences, 13(4), 273.
https://doi.org/10.3390/medsci13040273
